Doctors at the Conference on Retroviruses and Opportunistic Infections meeting say they cured an infant born with HIV for the first time by giving her a combination of therapies shortly after birth, reported Bloomberg.
The baby's treatment combined lamivudine and zidovudine, both sold by GlaxoSmithKline's joint venture with Pfizer, ViiV Healthcare, and Abbott Laboratories' Kaletra.
The baby was given a regimen of AIDS drugs about 30 hours after she was born at a rural Mississippi hospital, doctors said.
The mother, who had not taken medications that could have prevented the virus spreading to the fetus, took the child off the combination therapy at 18 months.
With no signs of the virus for 10 months, the infant was deemed "functionally cured," researchers said. The child, now two-and-a-half years old, remains free of HIV, according to the news source.